Search
4 studies match these filters. Showing 1–4 of 4 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT07636590 | Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 21 sites in total · contact listed | Recruiting | 500target | 21 / 1 | 2026 | Nov 18, 2026 | ||
| NCT06060041 | IC-8 Apthera IOL New Enrollment Post Approval Study The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 14 sites in total | Recruiting | 435target | 14 / 1 | 2023 | Jan 12, 2026 | ||
| NCT05561127 | Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel To determine the safety and efficacy of GIE Medical's ProTractX3™ TTS DCB for the treatment of recurrent benign bowel strictures. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 33 sites in total · contact listed | Recruiting | Phase 3 | 171target | 33 / 1 | 2023 | Jun 25, 2025 | |
| NCT07570316 | A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease The main purpose of this study is to look at how efgartigimod affects thyroid function in adults with Graves' Disease (GD). The study will also check whether efgartigimod is safe and well tolerated. It will look at how efgartigimod is distributed and eliminated in the body, how it changes antibody l… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 35 sites in total · contact listed | Recruiting | Phase 3 | 230target | 35 / 3 | 2026 | Nov 3, 2026 |